Sedana Medical AB (publ), First Quarter Report 2021
A quarter of launch preparations and continued increase in sales, lifted by the pandemicFinancial Summary This interim report has been prepared in accordance with IFRS with function-based income statement compared with cost-based income statement as previously. January-March 2021 · Net sales for the first quarter totalled MSEK 45 (34), equivalent to an increase of 33% on the same quarter in 2020. At fixed exchange rates, sales increased by 40%. · Gross profit was MSEK 29 (23), equivalent to a margin of 64% (67%). The lower margin is principally an effect of the continued high